|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/107 | |
| A61K 9/48 | |||
| A61K 31/568 | |||
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61K 47/44 |
| (11) | Patento numeris | 2803350 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14179390.1 |
| Europos patento paraiškos padavimo data | 2010-04-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (72) |
Dudley, Robert, E., US
Constantinides, Panayiotis, P., US
|
| (73) |
Clarus Therapeutics, Inc.,
555 Skokie Boulevard, Suite 340, Northbrook, IL 60062,
US
|
| (54) | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |